{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:45:36Z","timestamp":1790646336117,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Association Fran\u00e7aise Contre l\u2019Amylose"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00259-018-3963-x","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T13:39:11Z","timestamp":1520343551000},"page":"1108-1118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers"],"prefix":"10.1007","volume":"45","author":[{"given":"Eve","family":"Piekarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Chequer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Algalarrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Eliahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besma","family":"Mahida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Vigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel S.","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Le Guludec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Rouzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"3963_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C. A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of peripheral nerves. Brain. 1952;75:408\u201326.","journal-title":"Brain"},{"issue":"6","key":"3963_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1517\/14656566.2016.1145664","volume":"17","author":"D Adams","year":"2016","unstructured":"Adams D, Cauquil C, Labeyrie C, Beaudonnet G, Algalarrondo V, Th\u00e9audin M. TTR kinetic stabilizers and TTR gene silencing:a new era in therapy for familial amyloidotic polyneuropathies. Expert Opin Pharmacother. 2016;17(6):791\u2013802.","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"3963_CR3","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","volume":"99","author":"BG Ericzon","year":"2015","unstructured":"Ericzon BG, Wilczek HE, Larsson M, Wijayatunga P, Stangou A, Pena JR, et al. Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative? Transplantation. 2015;99(9):1847\u201354.","journal-title":"Transplantation"},{"issue":"8","key":"3963_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","volume":"79","author":"T Coelho","year":"2012","unstructured":"Coelho T, Maia LF, Martins da Silva A, Waddington Cruz M, Plant\u00e9-Bordeneuve V, Lozeron P, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology. 2012;79(8):785\u201392.","journal-title":"Neurology"},{"issue":"1","key":"3963_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12883-017-0948-5","volume":"17","author":"D Adams","year":"2017","unstructured":"Adams D, Suhr OB, Dyck PJ, Litchy WJ, Leahy RG, Chen J, et al. Trial design and rationale for APOLLO, a phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy. BMC Neurol. 2017 Sep 11;17(1):181.","journal-title":"BMC Neurol"},{"issue":"4","key":"3963_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13506129.2017.1374946","volume":"24","author":"MD Benson","year":"2017","unstructured":"Benson MD, Dasgupta NR, Rissing SM, Smith J, Feigenbaum H. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy. Amyloid. 2017 Dec;24(4):219\u201325.","journal-title":"Amyloid"},{"issue":"2","key":"3963_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","volume":"20","author":"A Castano","year":"2015","unstructured":"Castano A, Drachman BM, Judge D, Maurer MS. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev. 2015;20(2):163\u201378.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"3963_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jcmg.2014.03.007","volume":"7","author":"E Arbustini","year":"2014","unstructured":"Arbustini E, Merlini G. Early identification of transthyretin-related hereditary cardiac amyloidosis. J Am Coll Cardiol Img. 2014;7(5):511\u20134.","journal-title":"J Am Coll Cardiol Img"},{"issue":"10038","key":"3963_CR9","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387(10038):2641\u201354.","journal-title":"Lancet"},{"key":"3963_CR10","unstructured":"Algalarrondo V, Piekarski E, Eliahou L, Le Guludec D, Slama MS, Rouzet F. Can nuclear imaging techniques predict patient outcome and guide medical management decisions in hereditary transthyretin cardiac amyloidosis? Curr Cardiol Rep. In press."},{"issue":"3","key":"3963_CR11","doi-asserted-by":"publisher","first-page":"W256","DOI":"10.2214\/AJR.12.8737","volume":"200","author":"F Minutoli","year":"2013","unstructured":"Minutoli F, Di Bella G, Mazzeo A, Donato R, Russo M, Scribano E, et al. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol. 2013;200(3):W256\u201365.","journal-title":"AJR Am J Roentgenol"},{"issue":"21","key":"3963_CR12","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"MA Gertz","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66(21):2451\u201366.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"3963_CR13","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P, Popovi\u0107 ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442\u20138.","journal-title":"Heart"},{"issue":"3","key":"3963_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","volume":"38","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2011;38(3):470\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"24","key":"3963_CR15","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404\u201312.","journal-title":"Circulation"},{"issue":"8","key":"3963_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016;1(8):880\u20139.","journal-title":"JAMA Cardiol"},{"issue":"11","key":"3963_CR17","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging. 2014;15(11):1289\u201398.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"3963_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jcmg.2016.06.003","volume":"10","author":"M Haq","year":"2017","unstructured":"Haq M, Pawad S, Berk JL, Miller EJ, Ruberg FL. Can 99m-Tc-pyrophosphate aid in early detection of cardiac involvement in asymptomatic variant TTR amyloidosis? J Am Coll Cardiol Img. 2017;10(6):713\u20134.","journal-title":"J Am Coll Cardiol Img"},{"issue":"5","key":"3963_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MC Coutinho","year":"2013","unstructured":"Coutinho MC, Cortez-Dias N, Cantinho G, Concei\u00e7\u00e3o I, Oliveira A, Bordalo e S\u00e1 A, et al. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging. 2013;6(5):627\u201336.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"3963_CR20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jcmg.2016.07.008","volume":"9","author":"V Algalarrondo","year":"2016","unstructured":"Algalarrondo V, Antonini T, Th\u00e9audin M, Chemla D, Benmalek A, Lacroix C, et al. Cardiac Dysautonomia predicts long-term survival in hereditary transthyretin amyloidosis after liver transplantation. J Am Coll Cardiol Img. 2016;9(12):1432\u201341.","journal-title":"J Am Coll Cardiol Img"},{"issue":"7","key":"3963_CR21","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/ajt.13755","volume":"16","author":"MY Bechiri","year":"2016","unstructured":"Bechiri MY, Eliahou L, Rouzet F, Fouret PJ, Antonini T, Samuel D, et al. Multimodality imaging of cardiac transthyretin amyloidosis 16 years after a domino liver transplantation. Am J Transplant. 2016;16(7):2208\u201312.","journal-title":"Am J Transplant"},{"issue":"11","key":"3963_CR22","first-page":"1796","volume":"46","author":"A Cohen-Solal","year":"2005","unstructured":"Cohen-Solal A, Rouzet F, Berdeaux A, Le Guludec D, Abergel E, Syrota A, et al. Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. J Nucl Med. 2005;46(11):1796\u2013803.","journal-title":"J Nucl Med"},{"issue":"6","key":"3963_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46(6):1076\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3963_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","volume":"7","author":"S Longhi","year":"2014","unstructured":"Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M, et al. Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. J Am Coll Cardiol Img. 2014;7(5):531\u20132.","journal-title":"J Am Coll Cardiol Img"},{"issue":"1","key":"3963_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","volume":"121","author":"B Pilebro","year":"2016","unstructured":"Pilebro B, Suhr OB, N\u00e4slund U, Westermark P, Lindqvist P, Sundstr\u00f6m T. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Ups J Med Sci. 2016;121(1):17\u201324.","journal-title":"Ups J Med Sci"},{"issue":"8","key":"3963_CR26","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/RLU.0b013e318248512c","volume":"37","author":"P Rossi","year":"2012","unstructured":"Rossi P, Tessonnier L, Frances Y, Mundler O, Granel B. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis. Clin Nucl Med. 2012;37(8):e209\u201310.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"3963_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, et al. Role of 99mTc-DPD Scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. J Am Coll Cardiol Img. 2011;4(6):659\u201370.","journal-title":"J Am Coll Cardiol Img"},{"issue":"1","key":"3963_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/13506129.2013.871250","volume":"21","author":"AW Glaudemans","year":"2014","unstructured":"Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, et al. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid. 2014;21(1):35\u201344.","journal-title":"Amyloid"},{"issue":"9","key":"3963_CR29","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1253\/circj.CJ-16-0209","volume":"80","author":"G Bella Di","year":"2016","unstructured":"Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis. Circ J. 2016;80(9):1998\u20132003.","journal-title":"Circ J"},{"key":"3963_CR30","doi-asserted-by":"publisher","unstructured":"Moore PT, Burrage MK, Mackenzie E, Law WP, Korczyk D, Mollee P. The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience. Heart Lung Circ. 2017; \n                    https:\/\/doi.org\/10.1016\/j.hlc.2016.12.017\n                    \n                  .","DOI":"10.1016\/j.hlc.2016.12.017"},{"issue":"4","key":"3963_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","volume":"22","author":"A Galat","year":"2015","unstructured":"Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, et al. Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid. 2015;22(4):210\u201320.","journal-title":"Amyloid"},{"issue":"6","key":"3963_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","volume":"23","author":"A Casta\u00f1o","year":"2016","unstructured":"Casta\u00f1o A, DeLuca A, Weinberg R, Pozniakoff T, Blaner WS, Pirmohamed A, et al. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis. J Nucl Cardiol. 2016;23(6):1355\u201363.","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"3963_CR33","first-page":"201","volume":"23","author":"CA Coutinho","year":"2004","unstructured":"Coutinho CA, Concei\u00e7\u00e3o I, Almeida A, Cantinho G, Sargento L, Vagueiro MC. Early detection of sympathetic myocardial denervation in patients with familial amyloid polyneuropathy type I. Rev Port Cardiol. 2004;23(2):201\u201311.","journal-title":"Rev Port Cardiol"},{"key":"3963_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","volume":"29","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol. 1997;29:168\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"1-2","key":"3963_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jns.2014.07.017","volume":"345","author":"R Takahashi","year":"2014","unstructured":"Takahashi R, Ono K, Shibata S, Nakamura K, Komatsu J, Ikeda Y, et al. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. J Neurol Sci. 2014;345(1-2):231\u20135.","journal-title":"J Neurol Sci"},{"issue":"2 Pt 1","key":"3963_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","volume":"11","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R, et al. Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. J Am Coll Cardiol Img. 2018;11(2 Pt 1):234-42","journal-title":"J Am Coll Cardiol Img"},{"key":"3963_CR37","volume-title":"Autonomic innervation of the heart","author":"D Guludec Le","year":"2015","unstructured":"Le Guludec D, Delforge J, Dolle F. Imaging the parasympathetic cardiac innervation with PET. In: Slart R, Tio R, Elsinga P, Schwaiger M, editors. Autonomic innervation of the heart. Berlin: Springer; 2015."},{"key":"3963_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s003800300005","volume":"18","author":"H Kawano","year":"2003","unstructured":"Kawano H, Okada R, Yano K. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessel. 2003;18:32\u20139.","journal-title":"Heart Vessel"},{"issue":"2","key":"3963_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0002-8703(93)91056-K","volume":"126","author":"JS Gill","year":"1993","unstructured":"Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J. 1993;126(2):390\u20138.","journal-title":"Am Heart J"},{"issue":"4","key":"3963_CR40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s002590050406","volume":"26","author":"N Delahaye","year":"1999","unstructured":"Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med. 1999 Apr;26(4):416\u201324.","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"3963_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.md.0000232559.22098.c3","volume":"85","author":"N Delahaye","year":"2006","unstructured":"Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore). 2006 Jul;85(4):229\u201338.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"3963_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.acvd.2012.03.004","volume":"105","author":"V Algalarrondo","year":"2012","unstructured":"Algalarrondo V, Eliahou L, Thierry I, Bouzeman A, Dasoveanu M, Sebag C, et al. Circadian rhythm of blood pressure reflects the severity of cardiac impairment in familial amyloid polyneuropathy. Arch Cardiovasc Dis. 2012 May;105(5):281\u201390. \n                    https:\/\/doi.org\/10.1016\/j.acvd.2012.03.004\n                    \n                  .","journal-title":"Arch Cardiovasc Dis"},{"issue":"24","key":"3963_CR43","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1161\/hc4901.100380","volume":"104","author":"N Delahaye","year":"2001","unstructured":"Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, et al. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation. 2001 Dec 11;104(24):2911\u20136.","journal-title":"Circulation"},{"issue":"5","key":"3963_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jcmg.2014.03.002","volume":"7","author":"AV Kristen","year":"2014","unstructured":"Kristen AV, Scherer K, Buss S, aus dem Siepen F, Haufe S, Bauer R, et al. Noninvasive risk stratification of patients with transthyretin amyloidosis. J Am Coll Cardiol Img. 2014;7(5):502\u201310.","journal-title":"J Am Coll Cardiol Img"},{"issue":"4","key":"3963_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/13506129.2012.724035","volume":"19","author":"J Levy","year":"2012","unstructured":"Levy J, Hawkins PN, Rowczenio D, Godfrey T, Stawell R, Zamir E. Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly. Amyloid. 2012;19(4):201\u20133.","journal-title":"Amyloid"},{"issue":"5","key":"3963_CR46","first-page":"979","volume":"48","author":"LA Jones","year":"1991","unstructured":"Jones LA, Skare JC, Harding JA, Cohen AS, Milunsky A, Skinner M. Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy. Am J Hum Genet. 1991;48(5):979\u201382.","journal-title":"Am J Hum Genet"},{"issue":"1-2","key":"3963_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/BF00210764","volume":"90","author":"DR Jacobson","year":"1992","unstructured":"Jacobson DR, Rosenthal CJ, Buxbaum JN. Transthyretin pro 36 associated with familial amyloidotic polyneuropathy in an Ashkenazic Jewish kindred. Hum Genet. 1992;90(1-2):158\u201360.","journal-title":"Hum Genet"},{"issue":"2","key":"3963_CR48","first-page":"105","volume":"76","author":"M Chaves","year":"2016","unstructured":"Chaves M, Bettini M, Marciano S, S\u00e1ez S, Cristiano E, Rugiero M. Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina. Medicina (B Aires). 2016;76(2):105\u20138.","journal-title":"Medicina (B Aires)"},{"key":"3963_CR49","doi-asserted-by":"publisher","unstructured":"Zou X, Dong F, Zhang S, Tian R, Sui R. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor. Exp Eye Res. 2013; \n                    https:\/\/doi.org\/10.1016\/j.exer.2013.02.005\n                    \n                  .","DOI":"10.1016\/j.exer.2013.02.005"},{"key":"3963_CR50","doi-asserted-by":"publisher","unstructured":"Meng LC, Lyu H, Zhang W, Liu J, Wang ZX, Yuan Y. Hereditary transthyretin amyloidosis in eight Chinese families. Chin Med J. 2015; \n                    https:\/\/doi.org\/10.4103\/0366-6999.168048\n                    \n                  .","DOI":"10.4103\/0366-6999.168048"},{"issue":"2","key":"3963_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","volume":"68","author":"MS Maurer","year":"2016","unstructured":"Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, et al. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcomes Survey). J Am Coll Cardiol. 2016;68(2):161\u201372.","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-3963-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-3963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-3963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T04:07:45Z","timestamp":1551845265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-3963-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3963"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-3963-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"28 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}